Targeted Deprescribing in an Outpatient Hemodialysis Unit: A Quality Improvement Study to Decrease Polypharmacy

American Journal of Kidney Diseases

Volumn 70, Issue 5, 2017, Pages 611-618

  McIntyre, Caitlin ^a,b   McQuillan, Rory ^a,c   Bell, Chaim ^c   Battistella, Marisa ^a,b  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Deprescribing; elderly; end stage renal disease (ESRD); hemodialysis (HD); medication optimization; medication prescribing patterns; outpatient HD; patient safety; pill burden; polypharmacy; potentially inappropriate medications; quality improvement activity

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PROTON PUMP INHIBITOR; QUININE DERIVATIVE; WARFARIN; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; CENTRAL MUSCLE RELAXANT; QUININE;

ADULT; AGED; ALGORITHM; ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DEPRESCRIBING ALGORITHM; DRUG INDICATION; DRUG SPECIFIC MONITORING; EVIDENCE BASED MEDICINE; FEMALE; GASTROESOPHAGEAL REFLUX; HEALTH CARE CONCEPTS; HEMODIALYSIS PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; OUTCOME ASSESSMENT; OUTPATIENT DEPARTMENT; OUTPATIENT HEMODIALYSIS UNIT; PATIENT MONITORING; PATIENT SAFETY; PATIENT SATISFACTION; POLYPHARMACY; PRESCRIPTION; PROTOCOL COMPLIANCE; REIMBURSEMENT; SELF REPORT; TARGETED DEPRESCRIBING; TERTIARY CARE CENTER; TOTAL QUALITY MANAGEMENT; AMBULATORY CARE; DEPRESCRIPTION; HEMODIALYSIS; KIDNEY FAILURE, CHRONIC; MIDDLE AGED; ONTARIO; VERY ELDERLY;

ADRENERGIC ALPHA-ANTAGONISTS; ADULT; AGED; AGED, 80 AND OVER; AMBULATORY CARE; DEPRESCRIPTIONS; DIURETICS; FEMALE; HEMODIALYSIS UNITS, HOSPITAL; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; MUSCLE RELAXANTS, CENTRAL; ONTARIO; POLYPHARMACY; PROTON PUMP INHIBITORS; QUALITY IMPROVEMENT; QUININE; RENAL DIALYSIS; TERTIARY CARE CENTERS;

EID: 85017557872     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2017.02.374     Document Type: Article

References (31)

1. Maher, R.L., Hanlon, J., Hajjar, E., Clinical consequences of polypharmacy in elderly. Expert Opin Drug Saf 13:1 (2014), 57–65.
2. Scott, I.A., Gray, L.C., Martin, J.H., Pillans, P.I., Mitchell, C.A., Minimizing inappropriate medications in older populations: a 10-step conceptual framework. Am J Med 125:6 (2012), 529–537e1-e4.
3. Patterson, S.M., Hughes, C., Kerse, N., Cardwell, C.R., Bradley, M.C., Interventions to improve the appropriate use of polypharmacy for older people. Cochrane Database Syst Rev, 2012, 5 http://dx.doi.org/10.1002/14651858.CD008165.pub2.
4. Lindsay, J., Dooley, M., Martin, J., Fray, M., Kearney, A., Barras, M., Reducing potentially inappropriate medications in palliative cancer patients: evidence to support deprescribing approaches. Support Care Cancer 22 (2014), 1113–1119.
5. Gallagher, P.F., O'Connor, M.N., O'Mahony, D., Prevention of potentially inappropriate prescribing for elderly patients: a randomized controlled trial using STOPP/START criteria. Clin Pharmacol Ther 89:6 (2011), 845–854.
6. Scott, I.A., Gray, L.C., Martin, J.H., Pillans, P.I., Mitchell, C.A., Deciding when to stop: towards evidence-based deprescribing of drugs in older populations. Evid Based Med 18:4 (2013), 121–124.
7. Thompson, W., Farrell, B., Deprescribing: what is it and what does the evidence tell us?. Can J Hosp Pharm 66:3 (2013), 201–202.
8. Reeve, E., Wiese, M.D., Benefits of deprescribing on patients’ adherence to medications. Int J Clin Pharm 36 (2014), 26–29.
9. Manley, H.J., Garvin, C.G., Drayer, D.K., et al. Medication prescribing patterns in ambulatory haemodialysis patients: comparisons of USRDS to a large not-for-profit dialysis provider. Nephrol Dial Tranplant 19 (2014), 1842–1848.
10. Chiu, Y.W., Teitelbaum, I., Misra, M., de Leon, E.M., Adzize, T., Mehrotra, R., Pill burden, adherence, hyperphosphatemia, and quality of life in maintenance dialysis patients. Clin J Am Soc Nephrol 4:6 (2009), 1089–1096.
11. Garfinkel, D., Mangin, D., Feasibility study of a systematic approach for discontinuation of multiple medications in older adults. Arch Intern Med 170:18 (2010), 1648–1654.
12. Canadian Patient Safety Institute. Best possible medication history. http://www.patientsafetyinstitute.ca/en/Topic/Pages/Best-Possible-Medication-History.aspx. Accessed September 21, 2016.
13. Sica, D.A., Diuretic use in renal disease. Nat Rev Nephrol 8:2 (2011), 100–109.
14. Kalantar-Zadeh, K., Regidor, D.L., Kovesdy, C.P., et al. Fluid retention is associated with cardiovascular mortality in patients undergoing long-term hemodialysis. Circulation 119:5 (2009), 671–679.
15. Wanner, C., Krane, V., März, W., et al. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med 353:3 (2005), 238–248.
16. Fellström, B.C., Jardine, A.G., Schmieder, R.E., et al. Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. N Engl J Med 360:14 (2009), 1395–1407.
17. Baigent, C., Landray, M.J., Reith, C., et al. The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomized placebo-controlled trial. Lancet 377:9784 (2011), 2181–2192.
18. Wanner, C., Tonelli, M., and the Kidney Disease: Improving Global Outcomes Lipid Guideline Development Work Group Members. KDIGO clinical practice guideline for lipid management in CKD: summary of recommendation statements and clinical approach to the patient. Kidney Int 85:6 (2014), 1303–1309.
19. Raymond, C.B., Wazny, L.D., Treatment of leg cramps in patients with chronic kidney disease receiving hemodialysis. CANNT J 21:3 (2011), 19–21.
20. Korbin, S.M., Berns, J.S., Quinine-a tonic too bitter for hemodialysis-associated muscle cramps?. Semin Dial 20:5 (2007), 369–401.
21. Hurst, F.P., Neff, R.T., Falta, E.M., et al. Incidence, predictors and associated outcomes of prostatism after kidney transplantation. Clin J Am Soc Nephrol 4:2 (2009), 329–336.
22. Chang, T.I., Systolic blood pressure and mortality in patients on hemodialysis. Curr Hypertens Rep 13:5 (2011), 362–369.
23. Kwok, C.S., Arthur, A.K., Anibueze, C.I., Singh, S., Cavallazzi, R., Loke, Y.K., Risk of Clostridium difficile infection with acid suppressing drugs and antibiotics: meta-analysis. Am J Gastroenterol 107:7 (2012), 1011–1019.
24. Eom, C., Jeon, C.Y., Lim, J.W., Cho, E.G., Park, S.M., Lee, K.S., Use of acid suppressive drugs and risk of pneumonia: a systematic review and meta-analysis. CMAJ 183:3 (2011), 310–319.
25. Reeve, E., To, J., Hendrix, I., Shakib, S., Roberts, M.S., Wiese, M.D., Patient barriers to and enablers of deprescribing: a systematic review. Drugs Aging 30:10 (2013), 793–807.
26. Hayes, C., Surgical safety checklist: improved patient safety through effective teamwork. Healthcare Q 15:special issue (2012), 57–62.
27. Rhoads, M., Thai, A., Physician acceptance rate of pharmacist recommendations to reduce use of potentially inappropriate medications in the assisted living setting. Consult Pharm 18:3 (2003), 241–247.
28. Hanlon, J.T., Weinberger, M., Samsa, G.P., et al. A randomized, controlled trial of a clinical pharmacist intervention to improve inappropriate prescribing in elderly outpatients with polypharmacy. Am J Med 100:4 (1996), 428–437.
29. Bell, C.M., Fischer, H.D., Gill, S.S., et al. Initiation of benzodiazepines in the elderly after hospitalization. J Gen Intern Med 22:7 (2007), 1024–1029.
30. Scales, D.C., Fischer, H.D., Li, P., et al. Unintentional continuation of medications intended for acute illness after hospital discharge: a population-based cohort study. J Gen Intern Med 22:7 (2007), 1024–1029.
31. Reeve, E., Andrews, J.M., Wiese, M.D., Hendrix, I., Roberts, M.S., Shakib, S., The feasibility of a patient-centered deprescribing process to reduce inappropriate use of proton pump inhibitors. Ann Pharmacother 49:1 (2014), 29–38.